SCHEMBL24258447

SCHEMBL24258447

C=CC(F)(F)c1ccc(CCCCC2CC2)nc1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LSS P48449 2/20 0.32
DAO P14920 1/20 0.32
KDM1A O60341 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258341 0.79 PTPN2 (0.38) LSSMAOB
SCHEMBL24258401 0.73 DAO (0.32) DAOKDM1AMAOAMAOB
SCHEMBL14318720 0.72 NPC1 (0.40)
SCHEMBL9083096 0.71 NPC1 (0.39)
SCHEMBL9084823 0.69 CEL (0.34)
SCHEMBL9084589 0.68 LPL (0.34)
SCHEMBL9083040 0.68 HTR2A (0.34)
SCHEMBL17141772 0.67 ESR2 (0.39)
SCHEMBL1310810 0.67 DAO (0.47) DAOKDM1AMAOAMAOB
SCHEMBL9082717 0.67 CEL (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed